TSE:ADK Stock Latest News
Company AnnouncementsDiagnos accelerates Canadian rollout of AI-driven CARA eye diagnostic system1w ago
Company AnnouncementsDiagnos Seeks U.S. FDA Clarity on AI-Powered CARA Eye Screening System1M ago- Company AnnouncementsDiagnos Advances Global Regulatory Push for Next‑Generation CARA Eye‑Disease Platform6M ago
- Company AnnouncementsDiagnos Renews U.S. FDA Registration and Extends Warrant Expiry7M ago
- Company AnnouncementsDiagnos to Showcase AI Eye-Health Platform at Toronto Growth Investor Conference8M ago
Company AnnouncementsDiagnos Wins $1M-Plus Federal Backing for Next-Generation Retinal AI Research9M ago
Company AnnouncementsDIAGNOS Appoints New Chief AI Scientist to Propel Healthcare Innovation10M ago
Company AnnouncementsDiagnos Inc. Closes $4 Million Oversubscribed Private Placement10M ago
Company AnnouncementsDiagnos Inc. Upsizes Private Placement to $3.65M Amid Strong Demand11M ago
Company AnnouncementsDiagnos Inc. Extends Stock Warrant Exercise Period11M ago
Company AnnouncementsDiagnos Inc. Launches $2 Million Private Placement to Support Growth11M ago
Company AnnouncementsDiagnos Inc. Extends Stock Warrant Exercise Period1y ago- Company AnnouncementsDIAGNOS to Showcase Growth Potential at Bahamas Summit1y ago
Company AnnouncementsDIAGNOS Achieves MDSAP Audit Success, Paving Way for Global Expansion1y ago
Company AnnouncementsDIAGNOS Inc. Announces Shareholder Meeting Results and Stock Option Grants1y ago
Company AnnouncementsDiagnos Inc. Closes $100,000 Private Placement for AI Development1y agoCompany AnnouncementsDIAGNOS Inc. Announces $100,000 Private Placement for AI Product Development1y ago
Company AnnouncementsDiagnos Inc. Extends Stock Warrants Exercise Period and Corrects Previous Announcement1y ago
